Please assess the completion status of the following clinical trial:

Trial Title: Improvement of Sensibility in the Foot in Diabetic Patients Induced by EMLA-application to the Lower Leg

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (18-75 years) suffering from diabetes with subjective sensory impairment in the sole of the foot.~Exclusion Criteria:~* Patients with painful neuropathy or established ulcer formation in toes or sole of the foot, known hypersensitivity to local anaesthetics, major vascular reconstructions, communication problems due to severe language problems.~* Patients with pacemakers or magnetic implants or suffering from claustrophobia will not be subjected to fMRI-investigation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- EMLA cream (Type: EXPERIMENTAL): None
- Placebo cream (Type: PLACEBO_COMPARATOR): A placebo cream identical in appearance and consistency to the experimental cream

Based on this trial design, predict the completion outcome and termination type (if applicable).